A Phase I Study of CPX-351 in Combination with Busulfan and Fludarabine Conditioning and Allogeneic Stem Cell Transplantation in Adult Patients with Refractory Acute Leukemia Usama Gergis, Gail Roboz, Tsiporah Shore, Ellen Ritchie, Sebastian Mayer, Usama Wissa, Marshall McKenna, Paul Christos, Roger Pearse, Tomer Mark, Joseph Scandura, Koen van Besien, Eric Feldman Biology of Blood and Marrow Transplantation Volume 19, Issue 7, Pages 1040-1045 (July 2013) DOI: 10.1016/j.bbmt.2013.04.013 Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 1 Treatment schemes for schedules A and B. Biology of Blood and Marrow Transplantation 2013 19, 1040-1045DOI: (10.1016/j.bbmt.2013.04.013) Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 2 Kaplan-Meier analyses for all patients (n = 36). (A) LFS. (B) OS. (C) LFS by day 14 blasts. (D) OS by day 14 blasts. Biology of Blood and Marrow Transplantation 2013 19, 1040-1045DOI: (10.1016/j.bbmt.2013.04.013) Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions